These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 4231608)

  • 41. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The susceptibility of plasma to activation of fibrinolysis.
    Stief TW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):123-5. PubMed ID: 8457639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Biochemistry of urokinase].
    Duckert F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):131-41. PubMed ID: 4106001
    [No Abstract]   [Full Text] [Related]  

  • 44. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Properties of fibrinogenolysis and fibrinolysis products in immune assays.
    Beller FK; Maki M
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):114-32. PubMed ID: 4229208
    [No Abstract]   [Full Text] [Related]  

  • 46. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
    Bell WR
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S34-44. PubMed ID: 12556741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purification and properties of fibrin high-affinity urokinase from human urine.
    Hayashi S; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1244-54. PubMed ID: 3811788
    [No Abstract]   [Full Text] [Related]  

  • 48. A study of proteolytic and fibrinolytic factors in the human prostate.
    Nijs M; Brassinne C; Coune A; Tagnon HJ
    Thromb Diath Haemorrh; 1971 Jun; 25(3):481-98. PubMed ID: 4104828
    [No Abstract]   [Full Text] [Related]  

  • 49. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
    Theiss W; Asbeck F; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Marbert GA; van de Loo JC
    Thromb Haemost; 1983 Oct; 50(3):664-8. PubMed ID: 6196852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The immunoassay of human urokinase.
    Day ED; Ball AP; Jeffords D; Woodard WT; Silver D
    Thromb Diath Haemorrh; 1969 Apr; 21(2):273-86. PubMed ID: 4976768
    [No Abstract]   [Full Text] [Related]  

  • 51. [Value of various coagulation studies in the diagnosis of thromboses].
    Kuzin MI; Bokarev IN; Smolianitskiĭ AIa; Shumbalina LF; Dreĭzina AM
    Kardiologiia; 1974 Nov; 14(11):85-9. PubMed ID: 4279311
    [No Abstract]   [Full Text] [Related]  

  • 52. Fibrinolytic activation of plasma by means of urokinase in vitro and in vivo.
    Nanninga LB; Guest MM
    Thromb Diath Haemorrh; 1970 Oct; 24(1):33-42. PubMed ID: 5483972
    [No Abstract]   [Full Text] [Related]  

  • 53. Excercise-induced fibrinolytic activity and its effect on the degradation of fibrinogen, fibrin and fibrin-like precipitates.
    Gurewich V; Lipinska I; Lipinski B
    Thromb Res; 1974 Nov; 5(5):647-56. PubMed ID: 4445987
    [No Abstract]   [Full Text] [Related]  

  • 54. Fibrinolytic activity of human carcinomas. A comparative methodological study.
    Peterson HI; Petrusson B; Korsan-Bengtsen K
    Thromb Diath Haemorrh; 1973 Sep; 30(1):133-7. PubMed ID: 4788740
    [No Abstract]   [Full Text] [Related]  

  • 55. The activator time. A method for control of activator activity during thrombolytic therapy.
    Blix S
    Scand J Haematol; 1969; 6(4):221-6. PubMed ID: 5388562
    [No Abstract]   [Full Text] [Related]  

  • 56. [Determination of the components of fibrinolytic system].
    Slobozhankina IK
    Lab Delo; 1973; 11():662-4. PubMed ID: 4132568
    [No Abstract]   [Full Text] [Related]  

  • 57. [Possibilities of the method of fibrin plates for determination of the activity of the blood fibrinolytic system components].
    Butorov VN; Bokarev IN
    Lab Delo; 1978; (5):271-3. PubMed ID: 79009
    [No Abstract]   [Full Text] [Related]  

  • 58. Influence of homocysteine on fibrin network lysis.
    Lauricella AM; Quintana I; Castañon M; Sassetti B; Kordich L
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):181-6. PubMed ID: 16575255
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Modern concepts of the hemostatic and fibrinolytic systems].
    Andreenko GV
    Klin Med (Mosk); 1974 Apr; 52(4):13-23. PubMed ID: 4282102
    [No Abstract]   [Full Text] [Related]  

  • 60. [Fibrinolytic activity of the renal glomerulus. Preliminary results of a histochemical study of plasminogen activity in 44 renal biopsies].
    Arrigo G; Baroni M; Benuzzi S; Bellini A; Chiesa I; Colasanti G; D'Amico G
    Minerva Nefrol; 1979; 26(4):459-62. PubMed ID: 161611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.